Literature DB >> 2557508

Morphine-induced desensitization and down-regulation at mu-receptors in 7315C pituitary tumor cells.

P S Puttfarcken1, B M Cox.   

Abstract

Pituitary 7315c tumor cells maintained in culture were treated with varying concentrations of morphine from 10 nM to 300 microM, for periods of five or forty-eight hours. The ability of the mu-opioid receptor agonist, DAMGO, to inhibit forskolin-stimulated adenylyl cyclase in washed membrane preparations from the treated cells was compared with its activity in membranes from cells incubated in the absence of added morphine. In the same membrane preparations, the number and affinity of mu-opioid receptors was estimated by measurements of [3H]diprenorphine binding. After 5 hr of treatment with morphine concentrations of 100 nM or higher, a significant reduction in inhibition of adenylyl cyclase by DAMGO was observed. Little further loss of agonist activity was observed when the incubations were extended to 48 hr. After 5 hr of morphine treatment, there was no change in either the number of receptors, or their affinity for [3H]diprenorphine. However, after 48 hr of morphine treatment, greater than 25% reductions in receptor number were apparent with morphine pretreatment concentrations of 10 microM or higher. These results suggest that opioid tolerance in this system is primarily associated with a reduced ability of agonist-occupied receptor to activate the effector system. Receptor down-regulation was not necessary for loss of agonist response, although a reduction in receptor number occurred after exposure to high concentrations of morphine for periods longer than 5 hr.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2557508     DOI: 10.1016/0024-3205(89)90548-1

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  6 in total

Review 1.  Mechanisms of rapid opioid receptor desensitization, resensitization and tolerance in brain neurons.

Authors:  Vu C Dang; MacDonald J Christie
Journal:  Br J Pharmacol       Date:  2012-03       Impact factor: 8.739

2.  Chronic heroin self-administration desensitizes mu opioid receptor-activated G-proteins in specific regions of rat brain.

Authors:  L J Sim-Selley; D E Selley; L J Vogt; S R Childers; T J Martin
Journal:  J Neurosci       Date:  2000-06-15       Impact factor: 6.167

3.  Region-dependent attenuation of mu opioid receptor-mediated G-protein activation in mouse CNS as a function of morphine tolerance.

Authors:  L J Sim-Selley; K L Scoggins; M P Cassidy; L A Smith; W L Dewey; F L Smith; D E Selley
Journal:  Br J Pharmacol       Date:  2007-06-18       Impact factor: 8.739

4.  Differential desensitization of mu- and delta- opioid receptors in selected neural pathways following chronic morphine treatment.

Authors:  F Noble; B M Cox
Journal:  Br J Pharmacol       Date:  1996-01       Impact factor: 8.739

5.  Chronic morphine treatment up-regulates mu opioid receptor binding in cells lacking filamin A.

Authors:  Irma Onoprishvili; Eric J Simon
Journal:  Brain Res       Date:  2007-08-16       Impact factor: 3.252

6.  mu-Opioid receptor and alpha 2-adrenoceptor agonist binding sites in the postmortem brain of heroin addicts.

Authors:  A M Gabilondo; J J Meana; F Barturen; M Sastre; J A García-Sevilla
Journal:  Psychopharmacology (Berl)       Date:  1994-06       Impact factor: 4.530

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.